Eli Lilly and Co (HAM:LLY) E10: €7.89 (As of Mar. 2026)


HAM:LLY Eli Lilly and Co HAM:LLY
98 GF Score
Price €1,039.40
GF Value €1,212.75
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eli Lilly and Co E10?

Eli Lilly and Co HAM:LLY +3.96% 98 E10 is €7.89 as of Mar. 2026. GuruFocus rates HAM:LLY with a GF Score™ of 98/100 and a GF Value™ of €1,212.75 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €7.145. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €7.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Eli Lilly and Co's average E10 Growth Rate was 43.10% per year. During the past 3 years, the average E10 Growth Rate was 19.10% per year. During the past 5 years, the average E10 Growth Rate was 14.30% per year. During the past 10 years, the average E10 Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Eli Lilly and Co was 19.10% per year. The lowest was -2.70% per year. And the median was 5.90% per year.

As of today (2026-06-27), Eli Lilly and Co's current stock price is €1039.40. Eli Lilly and Co's E10 for the quarter that ended in Mar. 2026 was €7.89. Eli Lilly and Co's Shiller PE Ratio of today is 131.74.

During the past 13 years, the highest Shiller PE Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 54.54.


Eli Lilly and Co  (HAM:LLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1039.40/7.89
=131.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Eli Lilly and Co was 172.05. The lowest was 23.03. And the median was 54.54.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Eli Lilly and Co E10 Related Terms


Eli Lilly and Co E10 Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co E10 Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.89 4.58 4.56 5.90 7.02

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.82 5.96 6.19 7.02 7.89

HAM:LLY vs JNJ, ABBV, MRK: E10 Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.


HAM:LLY
98GF Score
Eli Lilly and Co HAM:LLY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=7.145/330.2130*330.2130
=7.145

Current CPI (Mar. 2026) = 330.2130.

Eli Lilly and Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.632 241.018 0.866
201609 0.650 241.428 0.889
201612 0.665 241.432 0.910
201703 -0.093 243.801 -0.126
201706 0.846 244.955 1.140
201709 0.445 246.819 0.595
201712 -1.335 246.524 -1.788
201803 0.941 249.554 1.245
201806 -0.214 251.989 -0.280
201809 0.960 252.439 1.256
201812 0.936 251.233 1.230
201903 3.814 254.202 4.954
201906 1.274 256.143 1.642
201909 1.244 256.759 1.600
201912 1.406 256.974 1.807
202003 1.448 258.115 1.852
202006 1.376 257.797 1.763
202009 1.129 260.280 1.432
202012 1.819 260.474 2.306
202103 1.252 264.877 1.561
202106 1.270 271.696 1.544
202109 1.037 274.310 1.248
202112 1.602 278.802 1.897
202203 1.907 287.504 2.190
202206 0.993 296.311 1.107
202209 1.626 296.808 1.809
202212 1.925 296.797 2.142
202303 1.392 301.836 1.523
202306 1.800 305.109 1.948
202309 -0.056 307.789 -0.060
202312 2.219 306.746 2.389
202403 2.282 312.332 2.413
202406 3.047 314.175 3.203
202409 0.964 315.301 1.010
202412 4.660 315.605 4.876
202503 2.830 319.799 2.922
202506 5.453 322.561 5.582
202509 5.291 324.800 5.379
202512 6.311 324.054 6.431
202603 7.145 330.213 7.145

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €7.89 mean?
Eli Lilly and Co (HAM:LLY) has a E10 of €7.89 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's E10 too high?
Eli Lilly and Co's current E10 is €7.89. Overall, Eli Lilly and Co has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's E10 compare to JNJ and ABBV?
Eli Lilly and Co's E10 of €7.89 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current E10 is €7.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (HAM:LLY) is currently considered Modestly Undervalued. The stock's GF Value™ is €1,212.75, compared to a current price of €1,039.40 — trading 14.3% below its estimated fair value. The current E10 is €7.89. Eli Lilly and Co's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Eli Lilly and Co (HAM:LLY), the current E10 is €7.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (HAM:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €1,039.40 is trading 14.3% below its estimated GF Value™ of €1,212.75. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for HAM:LLY:

  • E10: €7.89
  • GF Value™: €1,212.75 vs. price of €1,039.40 (14.3% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the HAM:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
98GF Score

Get the complete analysis for HAM:LLY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1,039.40
Price
€1,212.75
GF Value